Literature DB >> 30339180

General Relative Rate Models for the Analysis of Studies Using Case-Cohort Designs.

David B Richardson1, Bryan Langholz2, Kaitlin Kelly-Reif1.   

Abstract

A standard approach to analysis of case-cohort data involves fitting log-linear models. In this paper, we describe how standard statistical software can be used to fit a broad class of general relative rate models to case-cohort data and derive confidence intervals. We focus on a case-cohort design in which a roster has been assembled and events ascertained but additional information needs to be collected on explanatory variables. The additional information is ascertained just for persons who experience the event of interest and for a sample of the cohort members enumerated at study entry. One appeal of such a case-cohort design is that this sample of the cohort may be used to support analyses of several outcomes. The ability to fit general relative rate models to case-cohort data may allow an investigator to reduce model misspecification in exposure-response analyses, fit models in which some factors have effects that are additive and others multiplicative, and facilitate estimation of relative excess risk due to interaction. We address model fitting for simple random sampling study designs as well as stratified designs. Data on lung cancer among radon-exposed men (Colorado Plateau uranium miners, 1950-1990) are used to illustrate these methods.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30339180      PMCID: PMC8045475          DOI: 10.1093/aje/kwy223

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  21 in total

1.  Analysis of case-cohort designs.

Authors:  W E Barlow; L Ichikawa; D Rosner; S Izumi
Journal:  J Clin Epidemiol       Date:  1999-12       Impact factor: 6.437

2.  Computing the Cox model for case cohort designs.

Authors:  T M Therneau; H Li
Journal:  Lifetime Data Anal       Date:  1999-06       Impact factor: 1.588

3.  Estimation of the relative excess risk due to interaction and associated confidence bounds.

Authors:  David B Richardson; Jay S Kaufman
Journal:  Am J Epidemiol       Date:  2009-02-11       Impact factor: 4.897

4.  Practical considerations in choosing between the case-cohort and nested case-control designs.

Authors:  S Wacholder
Journal:  Epidemiology       Date:  1991-03       Impact factor: 4.822

5.  Fitting general relative risk models for survival time and matched case-control analysis.

Authors:  Bryan Langholz; David B Richardson
Journal:  Am J Epidemiol       Date:  2009-12-31       Impact factor: 4.897

6.  On the distinction between interaction and effect modification.

Authors:  Tyler J VanderWeele
Journal:  Epidemiology       Date:  2009-11       Impact factor: 4.822

7.  Conventional case-cohort design and analysis for studies of interaction.

Authors:  John Cologne; Dale L Preston; Kazue Imai; Munechika Misumi; Kengo Yoshida; Tomonori Hayashi; Kei Nakachi
Journal:  Int J Epidemiol       Date:  2012-07-18       Impact factor: 7.196

8.  General relative risk regression models for epidemiologic studies.

Authors:  S H Moolgavkar; D J Venzon
Journal:  Am J Epidemiol       Date:  1987-11       Impact factor: 4.897

9.  On the application of linear relative risk regression models.

Authors:  R L Prentice; M W Mason
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

10.  Case-cohort design in practice - experiences from the MORGAM Project.

Authors:  Sangita Kulathinal; Juha Karvanen; Olli Saarela; Kari Kuulasmaa
Journal:  Epidemiol Perspect Innov       Date:  2007-12-04
View more
  1 in total

1.  Lung and extrathoracic cancer incidence among underground uranium miners exposed to radon progeny in the Příbram region of the Czech Republic: a case-cohort study.

Authors:  Kaitlin Kelly-Reif; Dale P Sandler; David Shore; Mary Schubauer-Berigan; Melissa Troester; Leena Nylander-French; David B Richardson
Journal:  Occup Environ Med       Date:  2021-08-20       Impact factor: 4.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.